Class gram that is injectable infliximab, the use of the drug after anti-treatment without relapse time is not fixed, some patients need to to one or two years, there are some patients need to 4~5 years or even more time. Clinically there is also a part of the patients with the drug did not get obvious improvement.
Infliximab is a biological agent, which is good for controlling the inflammatory response, and the adverse reactions of the drug mainly include hives, eczema, hair loss, headache, and some patients may also experience generalized weakness or even chest pain. It is contraindicated for patients suffering from severe heart failure.
Crohn’s disease is a kind of inflammatory bowel disease, and the treatment mainly includes controlling the inflammatory response, symptomatic treatment and surgical treatment.
1. Inhibit the inflammatory response: according to the severity of the disease, you can choose Liuzosulfapyridine, azathioprine. At present, new drugs such as infliximab have been proved to be effective in controlling the acute exacerbation of Crohn’s disease, which is conducive to reducing complications.
2. Symptomatic treatment: the disease is prone to chronic diarrhea and loss of appetite, so it is usually necessary to strengthen the nutrition of the diet, and if necessary, transfuse human albumin.
3. Surgical treatment: If complications occur, such as acute perforation, hemorrhage and cancer, surgical treatment is needed.
Once diagnosed with Crohn’s disease, it is necessary to take a comprehensive approach to treatment, relying on a single drug to treat is not scientific, should follow the doctor’s instructions to standardize the treatment.